GSP Crop Science Q4 FY26 Results: PAT Rs 20 Cr
- May 28, 2026
- Posted by: Neeraj Pandey
- Category: News
GSP Crop Science Q4 FY26 results were declared on May 26, 2026. The company reported PAT of Rs 20 crore for the quarter ended March 31, 2026, down 9.1% YoY compared to Rs 22 crore in Q4 FY25. Revenue from operations was Rs 402 crore, up 30.5% YoY. Results are on a Consolidated basis. GSP Crop Science is a Agrochemicals company listed on Indian stock exchanges.
Click Here – Get Free Investment Predictions
GSP Crop Science Q4 FY26 Financial Highlights
| Metric | Q4 FY26 (Rs Cr) | Q4 FY25 (Rs Cr) | YoY Change |
|---|---|---|---|
| Revenue | Rs 402 crore | Rs 308 crore | +30.5% |
| Net Profit | 20 | 22 | -9.1% |
| Basis | Consolidated | ||
Note: GSP Crop Science Q4 FY26 results declared May 26, 2026. Data sourced from Screener.in BSE filings and verified news sources. Verify from audited statements before investment decisions.
GSP Crop Science Q4 FY26 Performance Analysis
The GSP Crop Science Q4 FY26 results reflect the company’s financial performance during the January to March 2026 quarter. Stable results reflect consistent business delivery. GSP Crop Science operates in the Agrochemicals sector, supported by India’s GDP growth above 6.5% and domestic demand conditions in FY26.
Revenue of Rs 402 crore was up 30.5% YoY. Strong revenue growth reflects market expansion and demand.
Screen the best stocks on the Univest Screener.
Key Factors Driving GSP Crop Science Q4 FY26 Results
Revenue and Business Performance
Revenue of Rs 402 crore in GSP Crop Science Q4 FY26 was up 30.5% YoY. Double-digit revenue growth reflects strong demand and market share gains. The January to March quarter is the fiscal year-end period characterised by strong execution cycles across Indian companies.
Profitability and Margin Trends
the business PAT of Rs 20 crore down 9.1% YoY. Stable profitability reflects consistent operational execution in the Agrochemicals sector.
India Macro Environment Q4 FY26
India’s macroeconomic environment in Q4 FY26 was supportive with GDP growth above 6.5%, government capex of Rs 11.21 lakh crore budgeted for FY27, and resilient domestic consumption. The RBI’s accommodative stance supported credit conditions. The Agrochemicals sector benefited from these structural tailwinds during the January to March 2026 quarter.
FY27 Outlook
Following the firm results, management guidance on FY27 revenue growth, margin improvement roadmap, and capital allocation priorities will be key investor watchpoints. The Agrochemicals sector continues to benefit from India’s long-term structural growth story. Consistent revenue growth and margin expansion remain the strategic priorities.
Download the Univest iOS App or the Univest Android App to get daily stock recommendations and expert research.
Sector Performance and Peer Comparison
The GSP Crop Science Q4 FY26 results come at a time when Indian corporate earnings for Q4 FY26 reflect the strength of India’s domestic consumption story. Companies across sectors reported their January to March 2026 quarter results on May 26, 2026, providing investors with a comprehensive view of FY26 corporate performance. GSP Crop Science’s results contribute to this broader earnings picture. Indian equities have benefited from strong institutional investor participation, stable macro fundamentals, and a supportive RBI monetary policy environment during FY26, creating a positive backdrop for listed companies across market capitalisations.
Key Investor Takeaways from GSP Crop Science Q4 FY26
For investors tracking GSP Crop Science, the Q4 FY26 results provide important data points on revenue trajectory, profitability trends, and operational efficiency. Key metrics to evaluate include revenue growth sustainability, margin direction, working capital management, and debt levels. The company’s performance relative to its sector peers and its ability to deliver consistent shareholder returns in FY27 will be closely monitored. Management’s guidance on order book, capacity utilisation, and strategic priorities during the results discussion will shape near-term investor sentiment for GSP Crop Science shares.
Frequently Asked Questions on the company
What is GSP Crop Science Q4 FY26 net profit?
Ans. GSP Crop Science Q4 FY26 PAT of Rs 20 crore, down 9.1% YoY from Rs 22 crore in Q4 FY25. Results declared May 26, 2026, on a Consolidated basis. Verify from BSE/NSE audited filings.
What is GSP Crop Science Q4 FY26 revenue?
Ans. GSP Crop Science Q4 FY26 revenue was Rs 402 crore, up 30.5% YoY. Verify from BSE/NSE filings.
When were GSP Crop Science Q4 FY26 results declared?
Ans. GSP Crop Science Q4 FY26 results were declared on May 26, 2026, at the board of directors meeting approving audited Q4 and full-year FY26 financial statements.
Is GSP Crop Science a good investment after Q4 FY26?
Ans. Investment decisions require individual assessment of fundamentals, valuation, and risk tolerance. This article is educational only. Consult a SEBI-registered financial advisor before investing.
Investments in securities are subject to market risk. This content is for educational purposes only. Verify all figures from BSE/NSE filings. Consult a SEBI-registered financial advisor.
